Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IGFBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BCKDHA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRSF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRYBB2P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFAS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ALOXE3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BST2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PBX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMB8-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JUP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF134 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADH1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARPP21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRHL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC22A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSRNP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on